|
|
Article: Researchers at Yale University, Department of Psychiatry target addiction medicine.(Clinical report)
- Article from:
- Biotech Week
- Article date:
- August 13, 2008
CopyrightCOPYRIGHT 2008 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
A new study, 'Disulfiram enhances subjective effects of dextroamphetamine in humans,' is now available. According to a study from the United States, "Disulfiram has shown promise in several clinical trials for cocaine addiction, but its potential utility in the treatment of amphetamine addiction has not been examined. The goal of this study was to determine the effects of disulfiram on acute physiological and subjective responses to dextroamphetamine in healthy volunteers."
"Five male and 5 female subjects participated in an outpatient double-blind, placebo-controlled, crossover study. Subjects were randomly assigned to a sequence of disulfiram (250 mg/day) or ...
Related newspaper, magazine, and journal articles:
|
|
Article: Research from Yale University, Medical Department ...
Biotech Week;
May 13, 2009 ;
700+ words
... ... and colleagues, Yale University, Medical Department ... C.S.R. Li, Yale University, School Medical ... States, New Haven, Addiction Medicine, Alcoholism, Behavior ... Mental Health, Yale University, Medical Department ...
|
|